Estrogen receptor alpha (ERα, ESR1) has been implicated in various liver diseases, including NAFLD, chronic hepatitis B (CHB), liver cirrhosis (LC) [22], and hepatocellular carcinoma (HCC) [23]. Here, ESR1 is linked to metabolic dysfunction-associated steatotic liver disease.